Optos introduces new retinal scanning device
This article was originally published in Clinica
Eye imaging firm Optos is launching a new ultra-wide field retinal imaging device, 200Tx, worldwide. The product is the first to incorporate auto-fluorescence technology to help detect changes in the retinal pigment epithelium, a pigmented cell layer just outside the retina. This could aid the diagnosis and management of age-related macular degeneration (AMD). Previously, the disorder was not thought to affect peripheral vision, but a study using 200Tx reported in September that 76% of eyes in 122 AMD patients had peripheral abnormalities, and that adding auto-fluorescence improved the detection of AMD (www.clinica.co.uk, 3 September 2010). Dunfermline, UK-based Optos exhibited the new device at the annual meeting of the American Academy of Ophthalmology, being held in Chicago, Illinois on 16-19 October, and plans to launch it commercially in the first quarter of 2011.